NCT04465357: Efficacy of Erenumab on Functional Impact of Migraine
- State
- Completed
- Phase
- Phase 4
- People
- 55 taking part
- Started
- 22 Oct 2020
- Primary completion
- 3 Jun 2022
- Arms
- Erenumab-Aooe 140 MG/ML [Aimovig]
- Results
- Posted on the registry
- 10 Jul 2020: Trial registered
- 22 Oct 2020: Trial started
- 3 Jun 2022: Trial completed
- 5 Oct 2022: Trial results posted